Sangamo Biosciences Inc. (SGMO) was a big mover last session with shares rising nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Nov 6, as the stock is now up nearly 36%.
This biopharmaceutical company saw no estimate revision in the last 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Sangamo Biosciences currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
However, better-ranked stocks in the same sector include Actelion Ltd. (ALIOF), Aeterna Zentaris Inc. (AEZS) and Heska Corp. (HSKA). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment